Eribaxaban

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameEribaxaban
Drug Alias Nameeribaxabanum艾立沙班依利沙班PD-348292PD-0348292
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsVenous Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksKEGG